We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Brazilan Ministry of Health and Biotools Announce Agreement

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Brazilan Ministry of Health and Biotools Announce Agreement"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
BIOTOOLS announces that an agreement has been reached with the Parana Molecular Biology Institute (IBMP), one of the main reference centers in Brazil, to create an epidemiological surveillance network.

• Signed agreement includes transfer technology and expects to set-up as many as 26 laboratories throughout Brazil, meeting the requirements of the Brazilian Ministry of Health Biotools has recently reached an agreement with IBMP to create an epidemiological surveillance network for the Brazilian Health System, including diagnostics and production technology transfer.

Biotools will transfer its proprietary technologies, and will provide reagents and equipment needed to establish up to 26 laboratories until the end of agreement. Biotools will also provide technical support for laboratory implementation as well as for their maintenance, enabling product development and solutions meeting particularities of Brazilian and South American epidemiology in general.

This agreement is part of the Strategic Plan of the Brazilian Health System for controlling health spending, and to achieve technological independence.

This way Biotools consolidates its business in Brazil, as in September 2009 also reached an agreement with the Brazilian Ministry of Health, implementing Biotools Technologies in a PCR-based blood screening program for HIV and Hepatitis C (HCV) in the Brazilian Public Health System.